Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death
Open Access
- 4 August 2021
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (8) , 2003
Abstract
DNA nanotechnology offers to build nanoscale structures with defined chemistries to precisely position biomolecules or drugs for selective cell targeting and drug delivery. Owing to the negatively charged nature of DNA, for delivery purposes, DNA is frequently conjugated with hydrophobic moieties, positively charged polymers/peptides and cell surface receptor-recognizing molecules or antibodies. Here, we designed and assembled cholesterol-modified DNA nanotubes to interact with cancer cells and conjugated them with cytochrome c to induce cancer cell apoptosis. By flow cytometry and confocal microscopy, we observed that DNA nanotubes efficiently bound to the plasma membrane as a function of the number of conjugated cholesterol moieties. The complex was taken up by the cells and localized to the endosomal compartment. Cholesterol-modified DNA nanotubes, but not unmodified ones, increased membrane permeability, caspase activation and cell death. Irreversible inhibition of caspase activity with a caspase inhibitor, however, only partially prevented cell death. Cytochrome c-conjugated DNA nanotubes were also efficiently taken up but did not increase the rate of cell death. These results demonstrate that cholesterol-modified DNA nanotubes induce cancer cell death associated with increased cell membrane permeability and are only partially dependent on caspase activity, consistent with a combined form of apoptotic and necrotic cell death. DNA nanotubes may be further developed as primary cytotoxic agents, or drug delivery vehicles, through cholesterol-mediated cellular membrane interactions and uptake.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (51NF40_182881, 310030L_182725/1, 31003A_173003/1)
This publication has 70 references indexed in Scilit:
- De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid SaturationCancer Research, 2010
- Cytochrome c Encapsulating Theranostic Nanoparticles: A Novel Bifunctional System for Targeted Delivery of Therapeutic Membrane-Impermeable Proteins to Tumors and Imaging of Cancer TherapyMolecular Pharmaceutics, 2010
- Mesoporous Silica Nanoparticles for Intracellular Delivery of Membrane-Impermeable ProteinsJournal of the American Chemical Society, 2007
- Assess the nature of cholesterol–lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayersProceedings of the National Academy of Sciences, 2007
- Folding DNA to create nanoscale shapes and patternsNature, 2006
- Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit β-strand alignmentNature Structural & Molecular Biology, 2004
- The antibacterial peptide ceratotoxin A displays alamethicin-like behavior in lipid bilayersPeptides, 2003
- Inhibition of Bax Channel-Forming Activity by Bcl-2Science, 1997
- Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane PoreScience, 1996
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 1996